Essity has signed a €400 million loan agreement with the European Investment Bank (EIB). The seven-year, favorable-term financing will support the company’s research, development, and innovation initiatives across all business areas, with a focus on combining sustainability and performance.
“The agreement with the EIB strengthens Essity’s innovation capabilities across all markets. From updating existing products to launching breakthrough solutions, we aim for innovations that improve people’s well-being, increase customer value, and reduce environmental impact,” says Ulrika Kolsrud, CEO of Essity.
The financing aims to consolidate European technological leadership in the hygiene and health sector while promoting the green transition and circular economy.
“European competitiveness depends on continuous investment in innovation that improves people’s daily lives. By supporting Essity’s research and innovation program, the EIB strengthens European technological leadership and sustainability,” says Karl Nehammer, Vice President of the EIB.
The European Investment Bank is the EU’s long-term financing institution, dedicated to supporting competitiveness, technological innovation, and sustainable development through investments in R&D projects conducted in Europe.